CellX Biosolutions Analysis: $2M Raised
What is CellX Biosolutions?
CellX Biosolutions develops patented bacterial consortia to degrade persistent chemical pollutants like PFAS, pharmaceuticals, agro-chemicals, and microplastics. Their technology uses microfluidics and robotics to isolate and scale bacteria capable of breaking down specific pollutants in water-based environments. The company targets industrial wastewater treatment and chemical storage reservoirs as key application areas.
Location
Zurich, Switzerland
Employees
1-10
Founded
2024
Funding Status
Pre-Seed
Product Features & Capabilities
- Biological treatment of long and short-chain PFAS
- Tailored biodiscovery and treatment solutions for specific chemical effluents
Use Cases
Degradation of PFAS in wastewater from API production; Treatment of pesticide and herbicide by-products in agro-chemical manufacturing; Removal of microplastics from natural water bodies; Custom bacterial solutions for industrial chemical effluents
Other Considerations
Featured in Deutsche Welle and SRF media coverage; Validated by public media for PFAS degradation capabilities; Backed by ETH Zurich research foundation
See something that needs updating? Suggest edits to this profile.